Stay updated on Ganaxolone in PCDH19 Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.

Latest updates to the Ganaxolone in PCDH19 Epilepsy Clinical Trial page
- Check5 days agoChange DetectedMinor UI tweaks and formatting adjustments were observed, with no substantive updates to the study details (e.g., inclusion criteria, outcomes, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check12 days agoNo Change Detected
- Check34 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that NI H Clinical Center is open and where to check status.SummaryDifference4%

- Check41 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

- Check55 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.3%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.3%

- Check70 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of new topics related to CDKL5 deficiency disorder and ganaxolone. However, several previously listed locations and resources have been removed.SummaryDifference3%

Stay in the know with updates to Ganaxolone in PCDH19 Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.